Company Filing History:
Years Active: 2021-2025
Title: Germaine Fuh-Kelly: Innovator in Immune Regulation
Introduction
Germaine Fuh-Kelly is a prominent inventor based in Pacifica, California. She has made significant contributions to the field of immunology, particularly through her innovative work on antibodies that target immune regulatory proteins. With a total of seven patents to her name, Fuh-Kelly is recognized for her groundbreaking research and development in this critical area of medicine.
Latest Patents
Among her latest patents, Fuh-Kelly has developed Anti-CD96 antibodies and methods of use thereof. This patent provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to the human CD96 receptor protein (hu-CD96). These antibodies are capable of decreasing, inhibiting, and fully blocking immune regulatory effects mediated by hu-CD96. The patent also outlines methods for using these antibodies to treat diseases and conditions that respond to the modulation of immune regulatory functions mediated by CD96 interactions.
Another significant patent is for Anti-CD200R1 antibodies and methods of use thereof. This invention includes binding proteins that specifically target the human CD200R1 receptor protein (hu-CD200R1). These antibodies can decrease, inhibit, and fully block immune regulatory effects mediated by hu-CD200R1. The patent further details methods for utilizing these antibodies to treat various diseases and conditions that require modulation of immune regulatory functions.
Career Highlights
Fuh-Kelly is currently employed at 23andMe, Inc., where she continues to advance her research in immunology. Her work has not only contributed to the scientific community but has also paved the way for potential therapeutic applications that could benefit patients suffering from immune-related conditions.
Collaborations
Throughout her career, Fuh-Kelly has collaborated with notable colleagues, including Yao-ming Huang and Erik E Karrer. These collaborations have enhanced her research efforts and contributed to the successful development of her patented technologies.
Conclusion
Germaine Fuh-Kelly is a distinguished inventor whose work in immune regulation has led to significant advancements in the field. Her innovative patents and ongoing research at 23andMe, Inc. highlight her commitment to improving healthcare through scientific discovery.